ATE120962T1 - Antithrombin-lösung und ihre verwendung. - Google Patents

Antithrombin-lösung und ihre verwendung.

Info

Publication number
ATE120962T1
ATE120962T1 AT91300196T AT91300196T ATE120962T1 AT E120962 T1 ATE120962 T1 AT E120962T1 AT 91300196 T AT91300196 T AT 91300196T AT 91300196 T AT91300196 T AT 91300196T AT E120962 T1 ATE120962 T1 AT E120962T1
Authority
AT
Austria
Prior art keywords
solution
antithrombin
orthopaedics
formations
patients
Prior art date
Application number
AT91300196T
Other languages
English (en)
Inventor
Kiyoshi Kita
Original Assignee
Kiyoshi Kita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kiyoshi Kita filed Critical Kiyoshi Kita
Application granted granted Critical
Publication of ATE120962T1 publication Critical patent/ATE120962T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT91300196T 1990-01-19 1991-01-11 Antithrombin-lösung und ihre verwendung. ATE120962T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008230A JPH03215430A (ja) 1990-01-19 1990-01-19 関節腔抗凝固剤

Publications (1)

Publication Number Publication Date
ATE120962T1 true ATE120962T1 (de) 1995-04-15

Family

ID=11687358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91300196T ATE120962T1 (de) 1990-01-19 1991-01-11 Antithrombin-lösung und ihre verwendung.

Country Status (7)

Country Link
EP (1) EP0438234B1 (de)
JP (1) JPH03215430A (de)
AT (1) ATE120962T1 (de)
AU (1) AU636431B2 (de)
CA (1) CA2033680A1 (de)
DE (1) DE69108748T2 (de)
DK (1) DK0438234T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0589871B1 (de) * 1990-02-13 2000-04-26 Ethicon, Inc. Peritoneal wirksame medikamente
US5589516A (en) * 1993-04-05 1996-12-31 The Green Cross Corporation Liquid preparation of antithrombin-III and stabilizing method therefor
KR100236771B1 (ko) * 1997-04-01 2000-02-01 성재갑 히아루론산을 이용한 약물의 서방성 미세입자 제형
DE19937656A1 (de) * 1999-08-13 2001-02-15 Aventis Behring Gmbh Verwendung von Antithrombin III zur Prophylaxe und Therapie von Erkrankungen
DE10102048A1 (de) * 2001-01-17 2002-07-18 Aventis Behring Gmbh Antithrombin III gegen durch Angiogenese verursachte Krankheiten
US7553827B2 (en) 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7344716B2 (en) 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US7429378B2 (en) 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US8361467B2 (en) * 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US8986696B2 (en) 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
EP2729164A4 (de) * 2011-07-07 2015-05-06 Lfb Usa Inc Formulierungen zur stabilisierung von proteinen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3618638A1 (de) * 1986-06-03 1987-12-10 Behringwerke Ag Verfahren zur sekretion von proteinen aus hefen
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
DE3624453A1 (de) * 1986-07-19 1988-01-28 Behringwerke Ag Verfahren zur herstellung von humanem antithrombin iii (atiii), dafuer geeignete vektoren und wirtszellen, so erhaltenes, biologisch aktives atiii und dieses enthaltende arzneimittel
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
US4877608A (en) * 1987-11-09 1989-10-31 Rorer Pharmaceutical Corporation Pharmaceutical plasma protein formulations in low ionic strength media

Also Published As

Publication number Publication date
AU6932691A (en) 1991-07-25
DE69108748T2 (de) 1995-09-14
DK0438234T3 (da) 1995-05-08
AU636431B2 (en) 1993-04-29
JPH03215430A (ja) 1991-09-20
EP0438234B1 (de) 1995-04-12
CA2033680A1 (en) 1991-07-20
EP0438234A1 (de) 1991-07-24
DE69108748D1 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
ATE120962T1 (de) Antithrombin-lösung und ihre verwendung.
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
CY1114734T1 (el) Φαρμακευτικες συνθεσεις και μεθοδοι χρησιμες για ρυθμιση αγγειογενεσης
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
DK275488D0 (da) Indolonderivater
DE3382458D1 (de) Haarwuchsmittel.
DE69428325D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
IE890580L (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
ATE56147T1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
ES2094757T3 (es) Un factor megacariocitopoyetico.
DE69530771D1 (de) Verwendung von 2-phenyl-3-aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
RU93029510A (ru) Способ противоишемической защиты тканей конечности
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
IL98200A0 (en) Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
AU5199286A (en) New use of 1,4-dihydropyridine derivatives
GR3018126T3 (en) 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent.
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
DE3778858D1 (de) 17-benzylspartein-derivate enthaltende positiv inotrop wirksame pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee